← Evidence map

ArticleJournal of the American Society of Nephrology : JASN2026

Recognizing Impact of SGLT2 Inhibitor Therapy on Quality of Life for Patients Living with CKD.

Kerri L Cavanaugh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41563338